Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (17)
  • 2024 (22)
  • 2023 (47)
  • 2022 (65)
  • 2021 (57)
  • 2020 (10)
  • 2019 (7)
  • 2018 (1)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Diversion Division (242)
  • Task Forces/Task Force Officers (230)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Scam Calls (5)

Drug Name

  • Oxycodone (47)
  • Opioids (45)
  • Fentanyl (26)
  • Hydromorphone (12)
  • Synthetic Opioids (12)
  • Benzodiazepines (7)
  • Morphine (7)
  • Ketamine (3)
  • Methadone (3)
  • Methamphetamine (3)
  • Steroids (3)
  • Amphetamines (2)
  • Cocaine (2)
  • GHB (1)
  • Heroin (1)

Field Division

  • Washington, DC (35)
  • St. Louis (32)
  • New York (21)
  • Chicago (19)
  • Miami (16)
  • Atlanta (12)
  • New Jersey (11)
  • Sede (11)
  • El Paso (10)
  • Dallas (9)
  • Houston (7)
  • San Francisco (7)
  • Seattle (7)
  • Louisville (5)
  • New England (5)
  • New Orleans (5)
  • San Diego (5)
  • Los Angeles (4)
  • Rocky Mountain (3)
  • Omaha (2)
  • Phoenix (2)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

Wisconsin Naturopathic Practitioner Sentenced to Twelve Months’ Imprisonment for Unlawful Prescribing of Controlled Substances

Mayo 15, 2023
MILWAUKEE - John J. McGarry, Assistant Special Agent in Charge of U.S. Drug Enforcement Administration-Milwaukee, and U.S. Attorney Gregory J. Haanstad for the Eastern District of Wisconsin, announced that on May 12, 2023, Michele Nickels. was sentenced to12 months and one day of imprisonment, to be followed by two years...
Mayo 15, 2023
PRESS RELEASE

DEA, SAMHSA Extend COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for Six Months While Considering Comments from the Public

Mayo 09, 2023
WASHINGTON – Today, ahead of the expiration of the COVID-19 Public Health Emergency (PHE), the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a temporary rule that extends telemedicine flexibilities...
Mayo 09, 2023
PRESS RELEASE

DEA to host summit on Medication for Opioid Use Disorder (MOUD) in Charleston, WV

Abril 04, 2023
Louisville, Ky. – The Drug Enforcement Administration (DEA) and the State of West Virginia are hosting a discussion on Medication for Opioid Use Disorder (MOUD) in Charleston, West Virginia on Saturday, April 15, 2023 from 12:00 p.m. to 5:00 p.m. The event will take place at the University of Charleston’s...
Abril 04, 2023
PRESS RELEASE

Indianapolis Pharmacy Technician Charged with Controlled Substances Violations

Marzo 24, 2023
INDIANAPOLIS - A joint investigation by Drug Enforcement Administration-Indianapolis and the Indianapolis Metropolitan Police Department (IMPD) has led to the arrest of Zennon Gaines, a pharmacy technician from Indianapolis, who has been charged with multiple violations, including felony dealing and possession of a controlled substance by fraud/forgery. The joint investigation...
Marzo 24, 2023
PRESS RELEASE

Panama City Physician Pays $225,000 to Settle Allegations that He Overprescribed Controlled Substances

Marzo 21, 2023
PENSACOLA, Fla. – Dr. George Barrio, a pain management physician who formerly practiced medicine at the NeuroMedical Institute in Panama City, agreed to pay $225,000 to resolve allegations that he unlawfully prescribed opioids and other controlled substances to patients. The settlement was announced by Jason R. Coody, United States Attorney...
Marzo 21, 2023
PRESS RELEASE

Former Nurse Sentenced for Stealing Opioids from Kansas Hospital

Marzo 13, 2023
KANSAS CITY, Kan. – A Kansas man was sentenced to 18 months in prison and his nursing license forfeited after stealing controlled substances from his employer. According to court documents, in March 2021, Alec Ramirez, 32, of Overland Park, Kan., removed vials of fentanyl and hydromorphone from an automated dispensing...
Marzo 13, 2023
PRESS RELEASE

Indiana Man Sentenced to 5 Years' Probation for Obtaining a Controlled Substance by Deception

Marzo 08, 2023
FORT WAYNE, Ind. – Alfred A. Cooke, Assistant Special Agent in Charge of Drug Enforcement Administration-Merrillville, Indiana, and U.S. Attorney Clifford D. Johnson for the Northern District of Indiana announced that Lucian Boboia, age 49, of Phoenix, Arizona, was sentenced before U.S. District Court Judge Holly A. Brady after pleading...
Marzo 08, 2023
PRESS RELEASE

DEA Announces Proposed Rules for Permanent Telemedicine Flexibilities

Febrero 24, 2023
WASHINGTON - Today, the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 public health emergency. The public will be able to comment for 30 days on the proposed rules. The...
Febrero 24, 2023
PRESS RELEASE

Physician Agrees to $190,731 Settlement Relating to Controlled Substances Act Claims

Febrero 24, 2023
PENSACOLA, Fla. – Timothy Ramsden, of Panama City, Florida, practicing at The Anti-Aging Clinic of Northwest Florida, settled potential violations of the Controlled Substances Act by agreeing to pay a fine of $190,731 and surrendering his Drug Enforcement Administration (DEA) registration for Schedule II and IIN controlled substances for a...
Febrero 24, 2023
PRESS RELEASE

Queens Pharmacist Pleads Guilty to Illegally Distributing Oxycodone and Filing False Tax Returns

Febrero 17, 2023
BROOKLYN – Daniel E. Russo pleaded guilty today in federal court in Brooklyn to conspiracy to distribute and possess with intent to distribute oxycodone, distribution and possession of oxycodone, and nine counts of filing false personal and corporate tax returns. The proceeding was held before United States District Judge Dora...
Febrero 17, 2023
Showing 71 - 80 of 229 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 4
  • Página 5
  • Página 6
  • Página 7
  • Current page 8
  • Página 9
  • Página 10
  • Página 11
  • Página 12
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster